Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300132
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,473
Award facts
- Contract value 100% obligated
- $9,473.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46250, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract is a Blanket Purchase Agreement (BPA) with a ceiling value of $9,473.25, awarded by the Department of Health and Human Services' Office of the Director.
The contract is for "DRUGS AND BIOLOGICALS" and does not have a set-aside designation, indicating it was awarded through open competition. Roche Diagnostics is an established federal contractor, holding multiple Indefinite Delivery Contracts (IDCs) and BPAs across agencies like the Department of Veterans Affairs, Defense Health Agency, and Centers for Disease Control and Prevention. These contracts cover a wide range of medical diagnostic technologies, including clinical chemistry analyzers, immunochemistry testing, molecular diagnostics, and specialized reagents for infectious disease testing.
The award to Roche Diagnostics supports the provision of critical laboratory equipment and services to federal healthcare agencies, contributing to medical research, disease detection, and patient care across various disciplines.
Quick answers
Who was awarded contract HHSN26300132?
HHSN26300132 was awarded to Roche Diagnostics Corporation by Office of the Director (National Institutes of Health) on April 14, 2014.
How much is contract HHSN26300132 worth?
The government has obligated $9,473 on HHSN26300132.
Is contract HHSN26300132 an order under another contract?
Yes. HHSN26300132 is a BPA call under HHSN263200400060630B, a blanket purchase agreement.
Was contract HHSN26300132 competed?
The extent of competition for HHSN26300132 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award